CVE detail

CVE-2023-41088 — CVE-2023-41088

Published 2023-10-19 · Modified 2026-06-17 · Vendor dexma · Product dexgate · Source nvd

MEDIUM

severity

CVSS-derived band

6.3

CVSS v3

0–10 scale

0.0024

EPSS probability

exploitation probability, 30d

15.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.